Vascular dysfunction in idiopathic dilated cardiomyopathy.
about
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingInduced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screeningEndothelial dysfunction and coronary artery disease: assessment, prognosis, and treatmentPatient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.Thyroid hormone promotes remodeling of coronary resistance vessels.Platelet endothelial cell adhesion molecule-1 mediates endothelial-cardiomyocyte communication and regulates cardiac function.ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activationUmbilical cord blood for cardiovascular cell therapy: from promise to fact.CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients.Restoration of thyroid hormone balance: a game changer in the treatment of heart failure?Thyroid Hormone and Cardioprotection.Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals.Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy.Deficiency of cartilage oligomeric matrix protein causes dilated cardiomyopathy.Effects of Transendocardial CD34+ Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy.The atrial appendage as a suitable source to generate cardiac-derived adherent proliferating cells for regenerative cell-based therapies.Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure.
P2860
Q26750618-6656336A-2E90-4D7A-833D-59FEB74AD47FQ26828408-916C8D61-B047-4C81-8D98-DB9B289AD66FQ26853087-5EA8F151-3B0A-4AD2-B060-8C877E778E4EQ30539904-2A7ACD09-A5F2-4D21-AE63-8139640DF1A6Q34037938-6B2468CF-BB5A-4C81-B97E-31EC363B7A16Q35088053-E8B77792-4640-454A-8C8F-FD346D27013BQ36409013-99800CF5-EEDA-421B-9E06-A6A2274E47C8Q38006735-8E71D981-EA31-4DC4-A1D8-A554E306C02CQ38125592-751A9C1B-9884-4749-AEA0-DE2FE9C27048Q38266177-BFEF0930-4387-4216-B05B-92C8F048A457Q38878221-C619B59D-EB38-4EF7-92DC-6368D772FAD8Q40267454-6AC0B347-DC1B-4C5A-A351-3D315A870B56Q41597749-4C979374-684F-4A56-B43A-30A2C3EE0B27Q43573244-689D4FFA-CB27-4791-BB0A-C43C597D244CQ46437166-4AE87E41-3A03-4447-98CB-C5769BA44BAFQ47871137-1F286814-793E-4CBB-B0DA-200BBA292C8BQ54957537-61CC4754-A562-4E23-B3BE-64705550C91F
P2860
Vascular dysfunction in idiopathic dilated cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vascular dysfunction in idiopathic dilated cardiomyopathy.
@en
Vascular dysfunction in idiopathic dilated cardiomyopathy.
@nl
type
label
Vascular dysfunction in idiopathic dilated cardiomyopathy.
@en
Vascular dysfunction in idiopathic dilated cardiomyopathy.
@nl
prefLabel
Vascular dysfunction in idiopathic dilated cardiomyopathy.
@en
Vascular dysfunction in idiopathic dilated cardiomyopathy.
@nl
P2860
P50
P1476
Vascular dysfunction in idiopathic dilated cardiomyopathy
@en
P2093
Santiago Roura
P2860
P304
P356
10.1038/NRCARDIO.2009.130
P407
P577
2009-07-28T00:00:00Z